Report - Nonclinical Safety Assessment of Biotherapeutics 11 - Plenary...Andreas Baumann, Bayer Rafael Ponce, Amgen Paul Andrews, Eisai Frank Brennan, UCB Tim McLachlan, Novartis Nonclinical

Please pass captcha verification before submit form